Skip to main content
Premium Trial:

Request an Annual Quote

Empire Genomics Lands $1M Financing

NEW YORK (GenomeWeb News) — Rand Capital and SCP Buffalo Incubator Innovate NY Fund said yesterday that they have invested $1 million in privately held molecular diagnostics firm Empire Genomics.

Based in Buffalo, NY, Empire Genomics offers testing products and services for cancer disease management that enable physicians to improve their diagnostic capabilities and tailor specific therapeutic treatments using patient DNA.

Empire Genomics was created in 2006 from research at Buffalo's Roswell Park Cancer Institute. The company has proprietary assays for prostate cancer and multiple myeloma, and its customers include hospitals, pharmaceutical clients, and academic centers.

The company said it will use the new funds to accelerate the pace of its growth by acquiring new technologies, growing staff, and increasing test offerings.